S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
The Dodgers gave Shohei Ohtani $700 million to hit and pitch — but also because he can sell
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Elon Musk restores X account of conspiracy theorist Alex Jones
At UN climate talks, cameras are everywhere. Many belong to Emirati company with a murky history
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The EU wants to put a tax on emissions from imports. It's irked some other nations at COP28
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
AP PHOTOS: Moscow hosts a fashion forum with designers from Brazil, China, India and South Africa
Military-themed brewery wants to open in a big Navy town. An ex-SEAL is getting in the way

Crescent Capital BDC Stock Price, News & Analysis (NASDAQ:CCAP)

$16.66
-0.04 (-0.24%)
(As of 12/8/2023 ET)
Compare
Today's Range
$16.64
$16.79
50-Day Range
$15.45
$17.01
52-Week Range
$12.56
$17.55
Volume
59,665 shs
Average Volume
91,562 shs
Market Capitalization
$617.45 million
P/E Ratio
10.82
Dividend Yield
9.84%
Price Target
$17.33

Crescent Capital BDC MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
4.0% Upside
$17.33 Price Target
Short Interest
Healthy
0.22% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
-2.67%
From $2.25 to $2.19 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars

Finance Sector

402nd out of 827 stocks

Nondepository Credit Institutions Industry

15th out of 44 stocks


CCAP stock logo

About Crescent Capital BDC Stock (NASDAQ:CCAP)

Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

CCAP Stock Price History

CCAP Stock News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Q3 2023 Crescent Capital BDC Inc Earnings Call
Crescent Capital BDC earnings preview: what Wall Street is expecting
Crescent Capital BDC, Inc. (487.F)
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
Q2 2023 Crescent Capital BDC Inc Earnings Call
See More Headlines
Receive CCAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Crescent Capital BDC and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2023
Ex-Dividend for 12/15 Dividend
11/29/2023
Today
12/10/2023
Dividend Payable
12/15/2023
Ex-Dividend for 1/16 Dividend
12/28/2023
Fiscal Year End
12/31/2023
Dividend Payable
1/16/2024
Next Earnings (Estimated)
2/28/2024

Industry, Sector and Symbol

Industry
Nondepository credit institutions
Sub-Industry
N/A
Sector
Finance
Current Symbol
NASDAQ:CCAP
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$17.33
High Stock Price Target
$18.00
Low Stock Price Target
$16.00
Potential Upside/Downside
+4.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$15.54 million
Pretax Margin
45.56%

Debt

Sales & Book Value

Annual Sales
$64.21 million
Cash Flow
$1.76 per share
Book Value
$19.83 per share

Miscellaneous

Free Float
36,702,000
Market Cap
$617.45 million
Optionable
Not Optionable
Beta
0.82
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report














CCAP Stock Analysis - Frequently Asked Questions

Should I buy or sell Crescent Capital BDC stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Crescent Capital BDC in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CCAP shares.
View CCAP analyst ratings
or view top-rated stocks.

What is Crescent Capital BDC's stock price target for 2024?

3 brokerages have issued twelve-month price objectives for Crescent Capital BDC's stock. Their CCAP share price targets range from $16.00 to $18.00. On average, they anticipate the company's stock price to reach $17.33 in the next year. This suggests a possible upside of 4.0% from the stock's current price.
View analysts price targets for CCAP
or view top-rated stocks among Wall Street analysts.

How have CCAP shares performed in 2023?

Crescent Capital BDC's stock was trading at $12.78 at the start of the year. Since then, CCAP shares have increased by 30.4% and is now trading at $16.66.
View the best growth stocks for 2023 here
.

Are investors shorting Crescent Capital BDC?

Crescent Capital BDC saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 81,400 shares, a decline of 20.4% from the October 31st total of 102,200 shares. Based on an average daily volume of 102,800 shares, the days-to-cover ratio is presently 0.8 days.
View Crescent Capital BDC's Short Interest
.

When is Crescent Capital BDC's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 28th 2024.
View our CCAP earnings forecast
.

How were Crescent Capital BDC's earnings last quarter?

Crescent Capital BDC, Inc. (NASDAQ:CCAP) released its earnings results on Wednesday, November, 8th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.56 by $0.03. The firm earned $48.15 million during the quarter, compared to analyst estimates of $47.12 million. Crescent Capital BDC had a trailing twelve-month return on equity of 10.73% and a net margin of 32.94%.

How often does Crescent Capital BDC pay dividends? What is the dividend yield for Crescent Capital BDC?

Crescent Capital BDC announced a quarterly dividend on Saturday, December 9th. Stockholders of record on Friday, December 29th will be given a dividend of $0.41 per share on Tuesday, January 16th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 9.84%. The ex-dividend date of this dividend is Thursday, December 28th. This is an increase from the stock's previous quarterly dividend of $0.09.
Read our dividend analysis for CCAP
.

Is Crescent Capital BDC a good dividend stock?

Crescent Capital BDC (NASDAQ:CCAP) pays an annual dividend of $1.64 per share and currently has a dividend yield of 9.81%. CCAP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 106.49%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, CCAP will have a dividend payout ratio of 74.89% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CCAP.

What ETFs hold Crescent Capital BDC's stock?

ETFs with the largest weight of Crescent Capital BDC (NASDAQ:CCAP) stock in their portfolio include Putnam BDC Income ETF (PBDC).Virtus Private Credit Strategy ETF (VPC).

What other stocks do shareholders of Crescent Capital BDC own?
Who are Crescent Capital BDC's major shareholders?

Crescent Capital BDC's stock is owned by many different institutional and retail investors. Top institutional shareholders include Mariner LLC (1.90%), Callodine Capital Management LP (0.48%), HighTower Advisors LLC (0.42%), Raymond James & Associates (0.39%), UBS Group AG (0.22%) and Quadrature Capital Ltd (0.17%). Insiders that own company stock include & Guaranty Life Insur Fidelity, Erik G Barrios, Gerhard Lombard, Jason Breaux, Joseph Hanlon, Kirill Bouek, Raymond Barrios and V Prem Et Al Watsa.
View institutional ownership trends
.

How do I buy shares of Crescent Capital BDC?

Shares of CCAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:CCAP) was last updated on 12/10/2023 by MarketBeat.com Staff

My Account -